Article thumbnail

Challenges of phase III trial design for novel treatments in diseases with no standard treatment: The AZA-001 myelodysplasia study model

By 
Publisher: 'Elsevier BV'
DOI identifier: 10.1016/j.leukres.2013.10.014
OAI identifier:
Provided by: MUCC (Crossref)
Sorry, our data provider has not provided any external links therefore we are unable to provide a link to the full text.

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.